Pilot study of alpidem, a new nonbenzodiazepine anxiolytic, in the treatment of generalized anxiety disorder.
D014151:Anti-Anxiety Agents / Q000627:therapeutic use*; D001008:Anxiety Disorders / Q000188:drug therapy*; D006801:Humans; D007093:Imidazoles / Q000627:therapeutic use*; D010865:Pilot Projects; D011725:Pyridines / Q000627:therapeutic use*
D014151:Anti-Anxiety Agents; D007093:Imidazoles; D011725:Pyridines; C052036:alpidem